vs
DigitalOcean Holdings, Inc.（DOCN）与Embecta Corp.（EMBC）财务数据对比。点击上方公司名可切换其他公司
Embecta Corp.的季度营收约是DigitalOcean Holdings, Inc.的1.1倍（$261.2M vs $242.4M），Embecta Corp.净利率更高（16.9% vs 10.6%，领先6.3%），DigitalOcean Holdings, Inc.同比增速更快（18.3% vs -0.3%），DigitalOcean Holdings, Inc.自由现金流更多（$31.1M vs $16.6M），过去两年DigitalOcean Holdings, Inc.的营收复合增速更高（14.5% vs -4.6%）
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
Embecta Corp.是一家专注于糖尿病护理领域的全球医疗科技企业，主要设计、生产及销售胰岛素笔针、注射器、输注组件等给药装置，产品服务覆盖全球多个地区的患者、医疗机构及生物制药合作方。
DOCN vs EMBC — 直观对比
营收规模更大
EMBC
是对方的1.1倍
$242.4M
营收增速更快
DOCN
高出18.5%
-0.3%
净利率更高
EMBC
高出6.3%
10.6%
自由现金流更多
DOCN
多$14.5M
$16.6M
两年增速更快
DOCN
近两年复合增速
-4.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $242.4M | $261.2M |
| 净利润 | $25.7M | $44.1M |
| 毛利率 | 58.7% | 61.9% |
| 营业利润率 | 16.0% | 31.9% |
| 净利率 | 10.6% | 16.9% |
| 营收同比 | 18.3% | -0.3% |
| 净利润同比 | 40.5% | — |
| 每股收益（稀释后） | $0.23 | $0.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCNEMBC
| Q4 25 | $242.4M | $261.2M | ||
| Q3 25 | $229.6M | $264.0M | ||
| Q2 25 | $218.7M | $295.5M | ||
| Q1 25 | $210.7M | $259.0M | ||
| Q4 24 | $204.9M | $261.9M | ||
| Q3 24 | $198.5M | $286.1M | ||
| Q2 24 | $192.5M | $272.5M | ||
| Q1 24 | $184.7M | $287.2M |
净利润DOCNEMBC
| Q4 25 | $25.7M | $44.1M | ||
| Q3 25 | $158.4M | $26.4M | ||
| Q2 25 | $37.0M | $45.5M | ||
| Q1 25 | $38.2M | $23.5M | ||
| Q4 24 | $18.3M | $0 | ||
| Q3 24 | $32.9M | $14.6M | ||
| Q2 24 | $19.1M | $14.7M | ||
| Q1 24 | $14.1M | $28.9M |
毛利率DOCNEMBC
| Q4 25 | 58.7% | 61.9% | ||
| Q3 25 | 59.6% | 60.0% | ||
| Q2 25 | 59.9% | 66.7% | ||
| Q1 25 | 61.4% | 63.4% | ||
| Q4 24 | 57.1% | 60.0% | ||
| Q3 24 | 60.2% | 60.7% | ||
| Q2 24 | 61.0% | 69.8% | ||
| Q1 24 | 60.7% | 64.6% |
营业利润率DOCNEMBC
| Q4 25 | 16.0% | 31.9% | ||
| Q3 25 | 19.6% | 21.4% | ||
| Q2 25 | 16.3% | 31.8% | ||
| Q1 25 | 17.9% | 24.3% | ||
| Q4 24 | 15.9% | 11.0% | ||
| Q3 24 | 12.4% | 9.2% | ||
| Q2 24 | 11.6% | 20.5% | ||
| Q1 24 | 6.2% | 13.6% |
净利率DOCNEMBC
| Q4 25 | 10.6% | 16.9% | ||
| Q3 25 | 69.0% | 10.0% | ||
| Q2 25 | 16.9% | 15.4% | ||
| Q1 25 | 18.1% | 9.1% | ||
| Q4 24 | 8.9% | — | ||
| Q3 24 | 16.6% | 5.1% | ||
| Q2 24 | 9.9% | 5.4% | ||
| Q1 24 | 7.7% | 10.1% |
每股收益（稀释后）DOCNEMBC
| Q4 25 | $0.23 | $0.74 | ||
| Q3 25 | $1.51 | $0.44 | ||
| Q2 25 | $0.39 | $0.78 | ||
| Q1 25 | $0.39 | $0.40 | ||
| Q4 24 | $0.21 | $0.00 | ||
| Q3 24 | $0.33 | $0.24 | ||
| Q2 24 | $0.20 | $0.25 | ||
| Q1 24 | $0.15 | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $254.5M | $201.3M |
| 总债务越低越好 | $1.3B | — |
| 股东权益账面价值 | $-28.7M | $-613.1M |
| 总资产 | $1.8B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOCNEMBC
| Q4 25 | $254.5M | $201.3M | ||
| Q3 25 | $236.6M | $225.5M | ||
| Q2 25 | $387.7M | $230.6M | ||
| Q1 25 | $360.4M | $209.3M | ||
| Q4 24 | $428.4M | $210.0M | ||
| Q3 24 | $439.9M | $267.5M | ||
| Q2 24 | $443.1M | $275.1M | ||
| Q1 24 | $419.1M | $299.8M |
总债务DOCNEMBC
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | $1.4B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | — | $1.6B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益DOCNEMBC
| Q4 25 | $-28.7M | $-613.1M | ||
| Q3 25 | $-69.6M | $-650.6M | ||
| Q2 25 | $-175.2M | $-669.6M | ||
| Q1 25 | $-210.7M | $-736.2M | ||
| Q4 24 | $-203.0M | $-768.8M | ||
| Q3 24 | $-211.7M | $-738.3M | ||
| Q2 24 | $-253.8M | $-763.7M | ||
| Q1 24 | $-286.1M | $-769.6M |
总资产DOCNEMBC
| Q4 25 | $1.8B | $1.1B | ||
| Q3 25 | $1.7B | $1.1B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.6B | $1.1B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.5B | $1.3B | ||
| Q1 24 | $1.5B | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $57.3M | $17.2M |
| 自由现金流经营现金流 - 资本支出 | $31.1M | $16.6M |
| 自由现金流率自由现金流/营收 | 12.8% | 6.4% |
| 资本支出强度资本支出/营收 | 10.8% | 0.2% |
| 现金转化率经营现金流/净利润 | 2.23× | 0.39× |
| 过去12个月自由现金流最近4个季度 | $180.5M | $205.8M |
8季度趋势，按日历期对齐
经营现金流DOCNEMBC
| Q4 25 | $57.3M | $17.2M | ||
| Q3 25 | $95.8M | $84.0M | ||
| Q2 25 | $92.4M | $81.2M | ||
| Q1 25 | $64.1M | $31.8M | ||
| Q4 24 | $71.3M | $-5.3M | ||
| Q3 24 | $73.4M | $26.6M | ||
| Q2 24 | $71.3M | $-2.1M | ||
| Q1 24 | $66.7M | $24.3M |
自由现金流DOCNEMBC
| Q4 25 | $31.1M | $16.6M | ||
| Q3 25 | $88.0M | $76.7M | ||
| Q2 25 | $59.3M | $80.8M | ||
| Q1 25 | $2.1M | $31.7M | ||
| Q4 24 | $26.1M | $-6.8M | ||
| Q3 24 | $16.0M | — | ||
| Q2 24 | $39.5M | $-11.8M | ||
| Q1 24 | $23.0M | $20.9M |
自由现金流率DOCNEMBC
| Q4 25 | 12.8% | 6.4% | ||
| Q3 25 | 38.3% | 29.1% | ||
| Q2 25 | 27.1% | 27.3% | ||
| Q1 25 | 1.0% | 12.2% | ||
| Q4 24 | 12.7% | -2.6% | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | 20.5% | -4.3% | ||
| Q1 24 | 12.5% | 7.3% |
资本支出强度DOCNEMBC
| Q4 25 | 10.8% | 0.2% | ||
| Q3 25 | 3.4% | 2.8% | ||
| Q2 25 | 15.2% | 0.1% | ||
| Q1 25 | 29.4% | 0.0% | ||
| Q4 24 | 22.1% | 0.6% | ||
| Q3 24 | 28.9% | 0.0% | ||
| Q2 24 | 16.6% | 3.6% | ||
| Q1 24 | 23.6% | 1.2% |
现金转化率DOCNEMBC
| Q4 25 | 2.23× | 0.39× | ||
| Q3 25 | 0.60× | 3.18× | ||
| Q2 25 | 2.50× | 1.78× | ||
| Q1 25 | 1.68× | 1.35× | ||
| Q4 24 | 3.91× | — | ||
| Q3 24 | 2.23× | 1.82× | ||
| Q2 24 | 3.73× | -0.14× | ||
| Q1 24 | 4.72× | 0.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
EMBC
| Pen Needles | $185.5M | 71% |
| Safety | $37.3M | 14% |
| Syringes | $30.7M | 12% |
| Manufacturing Facility | $4.1M | 2% |
